Eisai Inc., an oncology- and neurology-focused pharmaceutical company and the U.S. subsidiary of Eisai Co., Ltd., (based in Tokyo) announced the relocation of its New Jersey-based headquarters to the technologically-advanced and cutting-edge ON3 property in Nutley.
After decades of consolidation by Big Pharma, a host of smaller, younger life sciences companies have found space at legacy research sites throughout the Garden State.
Prism Capital Partners is one of New Jersey’s most active and respected developers focusing on the adaptive re-use and repurposing of excess corporate facilities and turn-of-the-century industrial buildings.
The intersection of urban vitality and suburban flexibility sits just nine miles from Manhattan at ON3.
Prism acquired this five-acre, former Lucas Chevrolet dealership property in Woodbridge and is transforming the under-utilized site into a luxury, mixed-use transit-oriented community.
Half a decade of planning and preparing has finally yielded to tangible headway at a significant adaptive reuse project in the Mile Square City, an expansion of which is starting to rise from the century-old structure.
Prism Capital Partners announced on Thursday it has donated a stockpile of critical safety gear to Hackensack Meridian Health‘s Hackensack University Medical Center.
Reflecting on a significant period of growth, Prism Capital Partners said Friday that it moved its headquarters from Bloomfield to ON3, the commercial real estate owner/operator’s 116-acre redevelopment spanning the Township of Nutley and City of Clifton
One of the state’s best-known commercial real estate families will receive NAIOP New Jersey’s lifetime achievement award, headlining the honorees at the association’s annual spring gala.
Multi-Use Tri-State Transformations